(NASDAQ: TNDM) Tandem Diabetes Care's forecast annual revenue growth rate of 11.29% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.05%.
Tandem Diabetes Care's revenue in 2026 is $1,014,736,000.On average, 26 Wall Street analysts forecast TNDM's revenue for 2026 to be $74,885,215,992, with the lowest TNDM revenue forecast at $71,332,267,788, and the highest TNDM revenue forecast at $77,686,578,999. On average, 26 Wall Street analysts forecast TNDM's revenue for 2027 to be $84,245,867,991, with the lowest TNDM revenue forecast at $77,139,971,583, and the highest TNDM revenue forecast at $92,923,260,720.
In 2028, TNDM is forecast to generate $96,066,253,362 in revenue, with the lowest revenue forecast at $84,519,171,699 and the highest revenue forecast at $114,377,601,798.